Tolerogenic Dendritic Cells and T-Regulatory Cells at the Clinical Trials Crossroad for the Treatment of Autoimmune Disease; Emphasis on Type 1 Diabetes Therapy
Tolerogenic dendritic cells and T-regulatory cells are two immune cell populations with the potential to prevent the onset of the clinical stage of type 1 diabetes and to manage the underlying autoimmunity beginning at the time-at-onset and onwards. Initial phase I trials demonstrated that the admin...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Revisão |
| Язык: | английский |
| Опубликовано: |
2019
|
| Online-ссылка: | https://doi.org/10.3389/fimmu.2019.00148 https://www.frontiersin.org/articles/10.3389/fimmu.2019.00148/pdf |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|